The Stomach in Health and Disease, Gut, vol.2015, issue.10, pp.1650-1668 ,
Chronic Helicobacter Pylori Infections Induce Gastric Mutations in Mice, Gastroenterology, vol.124, issue.5, pp.1408-1419, 2003. ,
, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Volume 61; International Agency for Research on Cancer (lARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol.61, 1994. ,
Epidemiology of Helicobacter Pylori Infection, Helicobacter, vol.19, issue.S1, pp.1-5, 2014. ,
Review Article: The Prevalence of Helicobacter Pylori and the Incidence of Gastric Cancer across Europe, Aliment. Pharmacol. Ther, vol.43, issue.3, pp.334-345, 2016. ,
Epidemiology and Diagnosis of Helicobacter Pylori Infection, Helicobacter, vol.20, pp.1-7, 2015. ,
, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part B: Biological Agents; International Agency for Research on Cancer (IARC Monographs on the Evaluation of Carcinogenic Risk to Human, 2012.
, P. Kyoto Global Consensus Report on Helicobacter Pylori Gastritis. Gut, pp.1-15, 2015.
, , pp.40-53
,
The European Helicobacter Study Group. Management of Helicobacter Pylori Infection-the Maastricht IV/ Florence Consensus Report, Gut, vol.2012, issue.5, pp.646-664 ,
, Helicobacter Pylori Eradication as a Strategy for Preventing Gastric Cancer; International Agency for Research on Cancer, 2014.
Effects of Helicobacter Pylori Treatment on Incidence of Gastric Cancer in Older Individuals, Gastroenterology, vol.155, issue.1, pp.67-75, 2018. ,
Population Screening and Treatment of Helicobacter Pylori Infection, Nat. Rev. Gastroenterol. Hepatol, vol.14, pp.230-240, 2017. ,
, Helicobacter Pylori Infection on Nutrition and Metabolism. World J. Gastroenterol, vol.20, issue.36, pp.12809-12817, 2014.
Extragastric Diseases and Helicobacter Pylori, Helicobacter, vol.20, pp.40-46, 2015. ,
, European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter Pylori Infection-the Maastricht V/Florence Consensus, pp.41-53
Antimicrobial Susceptibility Testing for Helicobacter Pylori in Times of Increasing Antibiotic Resistance, World J. Gastroenterol, vol.20, issue.29, pp.9912-9921, 2014. ,
Treatment of Helicobacter Pylori Infection: Current and Future Insights, World J. Clin. Cases, vol.2016, issue.1, pp.5-19 ,
Helicobacter Pylori and Antimicrobial Resistance: Molecular Mechanisms and Clinical Implications, Lancet Infect Dis, vol.6, issue.11, pp.699-709, 2006. ,
, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis, vol.18, pp.318-327, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02347423
Future Perspective for Potential Helicobacter Pylori Eradication Therapies, Future Microbiol, vol.13, issue.6, pp.671-687, 2018. ,
Prevalence of Antibiotic Resistance in Helicobacter Pylori: A Systematic Review and Meta-Analysis in World Health Organization Regions, Gastroenterology, vol.155, issue.5, pp.1372-1382, 2018. ,
Development of Vaccines against Helicobacter Pylori, Expert Rev. Vaccines, vol.8, issue.8, pp.1037-1049, 2009. ,
Vaccine against Helicobacter Pylori: Inevitable Approach, World J. Page, vol.42, p.53 ,
Helicobacter: Inflammation, Immunology, and Vaccines, Helicobacter, vol.23, p.12517, 2018. ,
Treatment of Helicobacter Pylori Infection: Meeting the Challenge of Antimicrobial Resistance, World J. Gastroenterol, vol.20, issue.29, pp.9898-9911, 2014. ,
Ureases as a Target for the Treatment of Gastric and Urinary Infections, J Clin Pathol, vol.63, issue.5, pp.424-430, 2010. ,
Identification of Potential Drug Targets in Helicobacter Pylori Strain HPAG1 by in Silico Genome Analysis ,
Drug Targets, vol.15, pp.106-117, 2015. ,
Crystal Structure of Oxidized Flavodoxin, an Essential Protein in Helicobacter Pylori, Protein Sci, vol.11, pp.253-261, 2002. ,
Common Conformational Changes in Flavodoxins Induced by FMN and Anion Binding: The Structure of Helicobacter Pylori Apoflavodoxin, Proteins, vol.69, pp.581-594, 2007. ,
The Flavodoxin from Helicobacter Pylori: Structural Determinants of Thermostability and FMN Cofactor Binding, Biochemistry, vol.47, issue.2, pp.627-639, 2008. ,
Structural Analysis of an Equilibrium Folding Intermediate in the Apoflavodoxin Native Ensemble by Small-Angle X-Ray Scattering, J. Mol. Biol, vol.406, issue.4, 2011. ,
Flavodoxins: Sequence, Folding, Binding, Function and Beyond, Cell. Mol. Life Sci, vol.63, pp.855-864, 2006. ,
Streptococcus Pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target, PLoS One, vol.11, issue.9, pp.1-25, 2016. ,
Identification of Carboxylation Enzymes and Characterization of a Novel Four-Subunit Pyruvate:flavodoxin Oxidoreductase from Helicobacter Pylori, J. Bacteriol, vol.177, issue.14, pp.3953-3959, 1995. ,
Quinone Reductase (FqrB): A Redox Partner of Pyruvate:Ferredoxin Oxidoreductase That Reversibly Couples Pyruvate Oxidation to NADPH Production in Helicobacter Pylori and Campylobacter Jejuni, J. Bacteriol, vol.189, issue.13, pp.4764-4773, 2007. ,
Helicobacter Pylori porCDAB and oorDABC Genes Encode Distinct Pyruvate:Flavodoxin and 2-Oxoglutarate:Acceptor Oxidoreductases Which Mediate Electron Transport to NADP, J. Bacteriol, vol.180, issue.5, pp.1119-1128, 1998. ,
Towards a New Therapeutic Target: Helicobacter Pylori Flavodoxin, Biophys. Chem, vol.115, issue.2-3, pp.267-276, 2005. ,
Conformational Stability of Helicobacter Pylori Flavodoxin Fit to Function at pH 5, vol.44, p.53 ,
Discovery of Specific Flavodoxin Inhibitors as Potential Therapeutic Agents against Helicobacter Pylori Infection, ACS Chem. Biol, vol.4, issue.11, pp.928-938, 2009. ,
Improved Flavodoxin Inhibitors with Potential Therapeutic Effects against Helicobacter Pylori Infection, J. Med. Chem, vol.56, issue.15, pp.6248-6258, 2013. ,
Nitroimidazole Drugs -Action and Resistance Mechanisms I. Mechanisms of Action, J. Antimicrob. Chemother, vol.31, pp.9-20, 1993. ,
Characterization of the NAD(P)H Oxidase and Metronidazole Reductase Activities of the RdxA Nitroreductase of Helicobacter Pylori, FEBS J, vol.276, issue.12, pp.3354-3364, 2009. ,
Structure of RdxA: An Oxygen Insensitive Nitroreductase Essential for Metronidazole Activation in Helicobacter Pylori, FEBS J, vol.2012, issue.23, pp.4306-4317 ,
Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases, J. Med. Chem, vol.60, pp.7636-7657, 2017. ,
Discovery and Synthesis of Novel Benzofurazan Derivatives as Inhibitors of Influenza A Virus, Bioorganic Med. Chem. Lett, vol.23, pp.5575-5577, 2013. ,
Silica Gel-Assisted Reduction of Nitrostyrenes to 2-Aryl-1-Nitroalkanes with Sodium Borohydride, Tetrahedron Lett, vol.24, issue.3, pp.227-230, 1983. ,
Palladium-Catalyzed Silane/Siloxane Reductions in the One-Pot Conversion of Nitro Compounds into Their Amines, Hydroxylamines, Amides, Sulfonamides, and Carbamates. Synthesis (Stuttg), pp.3316-3340, 2006. ,
A Simple Method for the Direct Oxidation of Aromatic Amines to Nitroso Compounds, J. Am. Chem. Soc, vol.82, issue.13, pp.3454-3456, 1960. ,
, , 1996.
Facile Synthesis of Fluorinated 1-Desazapurines. Synthesis (Stuttg), vol.11, pp.1865-1875, 2009. ,
, IV Spanish Consensus Conference on Helicobacter Pylori Infection Treatment, vol.39, pp.697-721, 2016.
Standardized Mouse Model of Helicobacter Pylori Infection: Introducing the Sydney Strain, Gastroenterology, vol.112, issue.4, pp.1386-1397, 1997. ,
, Docosahexaenoic Acid Inhibits Helicobacter Pylori Growth In Vitro and Mice Page, vol.46, p.53
, Gastric Mucosa Colonization, PLoS One, vol.7, p.35072, 2012.
Biophysical Screening for Identifying Pharmacological Chaperones and Inhibitors Against Conformational and Infectious Diseases, Curr. Drug Targets, vol.17, issue.13, pp.1492-1505, 2016. ,
Mode of Action of Metronidazole on Anaerobic Bacteria and Protozoa, Surgery, vol.93, issue.1, pp.165-171, 1983. ,
Mechanisms of Selective Toxicity of Metronidazole and Other Nitroimidazole Drugs, Br. J. Vener. Dis, vol.56, issue.5, pp.285-290, 1980. ,
Nitroimidazole Drugs -Action and Resistance Mechanisms II. Mechanisms of Resistance, J. Antimicrob. Chemother, vol.31, issue.2, pp.201-210, 1993. ,
Effects of Antibiotics on Human Microbiota and Subsequent Disease, Annu. Rev. Microbiol, vol.68, pp.217-235, 2014. ,
, Nature, vol.389, issue.6649, p.412, 1997.